Trial Profile
Sugammadex ED90 Dose to Reverse the Rocuronium Blockade in the Obese Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Sugammadex (Primary)
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- 09 Oct 2015 New trial record